The 2025 ISPE Pharma 4.0™ Conference, focused on enabling effective digital transformation in operations, will take place from 9–10 December in Barcelona, Spain, and virtually
NORTH BETHESDA, Md., Sept. 30, 2025 /PRNewswire/ — The International Society for Pharmaceutical Engineering (ISPE) has announced its keynote speakers for the 2025 ISPE Pharma 4.0™ Conference, set for Tuesday, 9 December, through Wednesday, 10 December, in Barcelona, Spain, and virtually.
“The 2025 ISPE Pharma 4.0™ Conference offers a unique opportunity for industry experts, regulators, and professionals from around the world to come together and connect, share resources, and navigate the evolving challenges and opportunities impacting life sciences,” said Mike Martin, President and CEO of ISPE. “With increasing industry pressure around cost and efficiency, and growing investments in AI, the event will address how to build credible, validated models for pharmaceutical manufacturing processes. Together, we’ll explore risk assessment frameworks, validation strategies, and approaches like the ISPE and GAMP®-related approaches like the ‘ISPE GAMP® Guide: Artificial Intelligence.'”
This year’s conference will feature eight technical tracks:
ISPE has announced its confirmed keynote speakers for the event:
Learn more and register for the 2025 ISPE Pharma 4.0™ Conference today by visiting ISPE.org/2025-Pharma-40.
About ISPE
The International Society for Pharmaceutical Engineering (ISPE) is a global nonprofit association serving its members through leading scientific, technical, and regulatory advancement across the entire pharmaceutical lifecycle. The 24,000+ members of ISPE provide solutions to complex pharmaceutical industry challenges through innovation, member and workforce development, and technical, regulatory, and compliance collaborations in more than 120 countries worldwide. Founded in 1980, ISPE has its worldwide headquarters and training center in North Bethesda, Maryland, USA, and its operations center in Tampa, Florida, USA. For more information, visit ISPE.org.
SOURCE ISPE
Telehealth Provider Offers FDA-Approved and Compounded Weight Loss Medications in All 50 States, Subject to…
Telehealth Platform Facilitates Compounded Semaglutide and Tirzepatide Access Through Licensed Provider Evaluation as FDA Shortage…
Analysis examines best peptides for boosting growth hormone as ReadyRx lists prescription sermorelin in injectable…
Discover the best fat burner for men in 2025. Explore Wolfson Brand’s effective fat-burning supplements…
Industry Analysis Examines How Cost, Safety, and Access Considerations Shape Semaglutide Choices as MEDVi Lists…
Deploying “Proof of Human” Infrastructure throughout Japan, a Technology Envisioned by Sam Altman and Alex…